v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
USD ($)
Sep. 30, 2022
USD ($)
Sep. 30, 2021
USD ($)
Cash flows from operating activities:      
Net cash provided by operating activities   $ 223,157 $ 273,980
Cash flows from investing activities:      
Proceeds from sale of property and equipment   65 32
Purchases of property and equipment   (4,388) (4,880)
Purchases of equity securities   (67,733) (46,532)
Purchases of available-for-sale debt securities   (178,788) (354,907)
Purchases of investment real estate, net   0 (7)
Proceeds from sales of equity securities $ 8,975 26,667 53,651
Proceeds from sales of available-for-sale debt securities   24,855 76,516
Proceeds from sales of investment real estate   0 2,591
Proceeds from sale of assets held for sale   0 8,856
Maturities of available-for-sale debt securities   59,291 70,095
Net cash provided by (used in) investing activities   (140,031) (194,585)
Cash flows from financing activities:      
Debt issuance costs paid   (131) 0
Preferred stock dividend   (8) (8)
Common stock dividend   (14,880) (15,104)
Purchase of treasury stock   (9,800) (1,609)
Payments related to tax withholding for share-based compensation   (209) (784)
Repayment of debt   (1,103) (1,103)
Net cash provided by (used in) financing activities   (26,131) (18,608)
Cash and cash equivalents and restricted cash and cash equivalents:      
Net increase (decrease) during the period   56,995 60,787
Balance, beginning of period   253,143 179,871
Balance, end of period 310,138 310,138 240,658
Cash and cash equivalents, and restricted cash and cash equivalents within the Consolidated Balance Sheets      
Cash and cash equivalents 307,435 307,435  
Restricted cash and cash equivalents 2,703 [1] 2,703 [1]  
Total cash and cash equivalents and restricted cash and cash equivalents $ 310,138 $ 310,138 $ 240,658
[1] See “—Note 5 (Insurance Operations)” for a discussion of the nature of the restrictions for restricted cash and cash equivalents and “—Note 14 (Variable Interest Entities)” for a discussion of restricted cash held in a trust account.